The 2021 Family Law Index is out now Find out more




Wealth & Investing

Life Sciences


Cambridge, United Kingdom

Advice type

Investment management

Asset class

Alternative assets


Sector focus

Investments and Asset Management

Drug Manufacturers

Medical Devices


Nick Galakatos


When the Blackstone Group observed that pharmaceutical companies faced severe pressures, it worried that key medical research might be severely thwarted.

The New York asset manager, which in 2018 already managed more than £337 billion, made an effort to bulk up its investments in healthcare by acquiring Clarus, a leading global life sciences investment firm. Nick Galakatos, who co-founded Clarus, now acts as the senior manager at Blackstone Life Sciences with over 30 years of experience in the healthcare and finance sectors. He has led investments in biotechnology, pharmaceutical company partnerships and diagnostics, from start-ups to commercial-stage companies.

Rank: Top Recommended

Top Recommended 2021, Life Sciences

Share on